OraSure Technologies (OSUR) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 5/14/2024
- Nasdaq hits record close after Powell reassures investors, CPI in focus
- Powell says Fed's restrictive policy is working
- JPMorgan says not worth 'taking on equity risk' now
- Alphabet debuts beefed-up AI search and chatbot as competition heats up
- World stock index set for record high, dollar dips after PPI, Powell
- GameStop (GME) Halted on Circuit Breaker, Up 54%
- AMC Entertainment (AMC) Halted on Circuit Breaker, Up 121%
- Andy Jassy makes AWS leadership announcement (AMZN), says Matt Garman will become CEO of AWS
- Squarespace, Inc. (SQSP) To Go Private For $44/shr In Cash With Permira
- GameStop (GME) Halted Again on Volatility, Up 69%
- After-hours movers: AMC Entertainment, DLocal, Boot Barn, and more
- Midday movers: GameStop, AMC Entertainment rise; Alibaba falls
- After-hours movers: AMC Entertainment, StoneCo, Fulcrum Therapeutics, and more
- Midday movers: Intel, Arm, Apple, GameStop rise; Alphabet falls
- Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
OraSure Announces 2015 First Quarter Financial Results
May 6, 2015 4:00 PM EDTBETHLEHEM, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the first quarter ended March 31, 2015.
Financial Highlights
Consolidated net revenues for the first quarter of 2015 were $27.1 million, a 15% increase from the comparable period of 2014.  Net product revenues for the Company's OraQuick® rapid HCV test were $2.2 million for the first quarter of 2015, representing a 39% increase over the first quarter of 2014. Total HCV-related revenues, including exclusivity payments recognized under the HCV co-promotion... More
